# Safety and Efficacy of Immune Therapy for Condyloma

> **NCT03158480** · NA · UNKNOWN · sponsor: **Shenzhen Second People's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Condylomata Acuminata

## Interventions

- **BIOLOGICAL:** DC-CIK immunotherapy

## Key facts

- **NCT ID:** NCT03158480
- **Lead sponsor:** Shenzhen Second People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-25
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158480, "Safety and Efficacy of Immune Therapy for Condyloma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03158480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*